Table 2

Antagonist pharmacology of hGluR3i determined by [Ca++]i measurements in HEK69-8 cells

CompoundIC50valuesnHKbvaluesStatisticsn
μM μM
NBQX0.38  (0.28, 0.52)−1.1  ± 0.20.31  (0.22, 0.42) c,d,y,s,g 4
DNQX2.09  (1.73, 2.52)−1.3  ± 0.11.66  (1.38, 2.00) n,s,g 4
YM-90K2.45  (2.04, 2.93)−1.5  ± 0.21.96  (1.64, 2.35) n,s,g 3
CNQX2.64  (2.13, 3.28)−1.1  ± 0.22.11  (1.68, 2.67) n,s,g 8
NS25710.5  (7.33, 15.2)−1.5  ± 0.38.45  (5.87, 12.2) n,c,d,y,g 4
GYKI-5246634.0  (22.5, 51.5)−1.3  ± 0.13
GAMS1140  (977, 1331)−1.5  ± 0.2913  (782, 1070) n,c,d,y,s 4
AMOA≫3004
NS102≫3004

Kb or IC50 values determined for antagonists against hGluR3i, expressed as the geometric mean (lower, upper S.E.), and the Hill slope, nH, expressed as the mean ± S.E. Antagonist studies were performed with 30 μM glutamate. The dissociation constants (Kb values) were derived from IC50 values with the Leff-Dougall variant of the Cheng-Prusoff equation (Leff and Dougall, 1993). † Kb values were not calculated because GYKI-52466 is a noncompetitive antagonist. Statistics were performed onKb values with ANOVA followed by Student-Newman-Keuls pairwise comparison. Differences (P < .05) are indicated by the letters: n, c, d, y, s and gwhere values are different from NBQX, CNQX, DNQX, YM-90K, NS257 and GAMS, respectively.